DeFilippis AP et al. |
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. |
2014 |
Nutr Metab Cardiovasc Dis |
pmid:24370448
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Dudley A et al. |
Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. |
2013 Jan-Feb |
J. Vet. Intern. Med. |
pmid:23278865
|
Gremmel T et al. |
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. |
2013 |
J. Atheroscler. Thromb. |
pmid:23739624
|
Nakamura A et al. |
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. |
2013 |
Circ. J. |
pmid:23676973
|
Vazzana N et al. |
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. |
2013 |
J Am Heart Assoc |
pmid:23557750
|
DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|